The results of the first 400 consecutive patients (335 males, 65 females; mean age 52 years) having saphenous vein-coronary artery graft surgery at Stanford between October 1968 and January 1972 were reviewed. Through patient or physician contact, 100% follow-up period was achieved in the 375 patients surviving surgery. The mean follow-up period was 9.9 months, with the range 2 to 40 months. The operative mortality was 6.5%; patients having this surgery electively had a 0.8% mortality. The major cause of operative mortality was myocardial infarction (9 patients) and congestive heart failure and cardiogenic shock (10 patients). Predominant postoperative morbidity was due to pulmonary emboli (17 patients) and intrathoracic hemorrhage requiring thoracotomy (11 patients). The use of anticoagulants in the early postoperative period has reduced the incidence of pulmonary emboli. Angina was completely relieved in 79% (295 patients), 237 of whom had returned to full time employment. However, another 12% either were unchanged from their preoperative symptomatic state or incurred major late complications. This group includes 15 patients (3.9%) who had late deaths from cardiovascular causes. Another 23 patients had late, nonfatal myocardial infarctions. Using as a data base the degree of preoperative congestive heart failure, the extent of electrocardiographic changes and the presence of mitral regurgitation, a prognostic preoperative clinical risk-benefit guideline has been developed for use in any patient undergoing saphenous vein coronary artery graft surgery. 
12. Degree of clinical shock preoperatively [0 -4] 0 blood pressure >120/X 1 blood pressure <100/X with minimal therapy 2 blood pressure <100/X with intensive therapy 3 = blood pressure <100/X with adequate perfusion but oliguria 4 Abbreviations: NYHA = New York Heart Associatioln; CHF = congestive heart failure; D)OE = dyspruea on exertion; PNI) = paroxysmal nocturnial dyspnea; LVEI)P = left ventricular end-diastolic pressure; LVH left ventricular hypertrophy. The operative technique utilized in this series of 400 patients has been essentially the same. Moderate hypothermia (30-33°C) and electrical fibrillation of the heart have been employed; local hypothermia using 4°C normal saline instilled into the pericardial well has been used in selected circumstances. Aortic crossclamping has been minimized. Perfusion flow rates have been between 2,000 and 3,000 cc/min. The average pump time for the entire group was 115 min, ranging from 60 to 240 min. Preoperatively and postoperatively patients were treated with broad spectrum antibiotics. Since March 1971 the patients have received oral anticoagulants for six weeks postoperatively, unless there were some contraindications. The 400 patients in this series had a total of 406 saphenous vein bypass operations, implying that six patients necessitated re-operation after discharge from the hospital. Of the 400 patients, 375 survived operation, for an overall operative mortality of 6.2%. It is clear that the operative mortality was related to the preoperative NYHA classification of functional capacity, as shown in table 5. In NYHA classes I and II, the total of 113 patients had no operative deaths. Those patients in class IV, of whom there were 149, experienced 21 operative deaths, which accounted for 84% of the surgical mortality (operative mortality was considered if the patient died within 24 hours of the initial operation).
The patient with angina pectoris undergoing an elective saphenous vein bypass procedure had a different prognosis from the patient who came to surgery with either class IV angina, fulminant congestive heart failure, severe cardiogenic shock, or severe electrocardiographic changes as outlined. For example, if patients with these latter clinical findings are excluded, as well as those patients who had associated surgical procedures such as valve replacement or ventricular resection, 249 patients remain, of whom two died, giving an operative mortality of 0.8% in this population of favorable candidates. If the 29 patients having class IV congestive heart failure are excluded from the overall series, there were 11 operative deaths in the total series, yielding a surgical mortality of 2.9%. We have previously reported our experience with those patients presenting with "pre-infarction angina," where we have experienced an operative mortality of 10.7% in 67 patients. 7 The operative procedures performed in the 406 operations are summarized in table 6. Two hundred and forty-two patients had multiple grafts; more grafts were placed as experience with the procedure increased. A simultaneous aortic or mitral valve replacement did not significantly affect the operative mortality in this group of patients. Table 7 summarizes which grafts were placed. The number of coronary endarterectomies performed has diminished in the past 18 months, as an increased incidence of intraoperative myocardial infarction and late arterial occlusion has been documented.
The causes of the 25 operative deaths are listed in table 8; the most common causes were 'pump failure" (ten patients) and myocardial infarction (nine patients).
A significant number of patients incurred postoperative complications. Fifty eight patients, or 14.2% of the entire series, experienced major morbidity as summarized in table 9. The leading cause of postoperative morbidity was pulmonary embolization, which occurred in 17 patients. The occurrence of this complication has been reduced significantly since institution of routine postoperative anticoagulation. In this series, patients taken back to the operating room for re-exploration experienced no added mortality. Bleeding was usually traced to extra-cardiac sources. Of note is the fact that there were five patients who experienced documented nonfatal myocardial infarctions within the hospital prior to their discharge. These were remarkably benign clinically. In those cases in which early angiographic studies were performed, infarction was usually associated with occlusion of one of the saphenous vein grafts.
Of the 375 patients surviving surgery, follow-up has been obtained in 100% of the cases. The mean follow-up time is 9.9 months, with a standard deviation of 5.9 months. The range of follow-up is from a minimum of two months to a maximum of 40 months.
The postoperative clinical outcome for the 375 surviving patients is summarized in table 10. Two hundred and ninety five of these patients (79%) are entirely angina-free ( fig. 1 ). Of these, 237 have returned to full time work and/ or full physical activity. If, in terms of overall outcome, scores of one, two and three are considered a clinical improvement in the patient's functional status, then 300 of the 375 patients being discharged from the hospital, or 88%, derived benefit from the procedure itself.
The remaining 12% were considered to have derived no benefit from the procedure, having either no change or an increase in their anginal status, incurring a late myocardial infarction, or dying of a cardiovascular event. There were 15 late cardiovascular deaths which have been analyzed. Nine of these were thought to be due to congestive heart failure, two to acute myocardial infarction, Figure 1 Shown in diagrammatic form are the overall symptomatic results in the 375 patients surviving surgery at a mean follow-up time of 9.9 months. Abbreviations: MI = myocardial infarction; C-V = cardiovascular; Sx = symptoms; = increased; 4. = decreased. and four occurred suddenly, presumably due to associated arrhythmia. In addition, there have been 23 late nonfatal myocardial infarctions which constitute 6% of those surviving the operation.
When the survival experience of the total group was analyzed actuarially by the method of Kaplan and Meier, 30 day survival was calculated at 93.4% and the one year survival was calculated at 88.5%. There have been no deaths among patients surviving more than one year postoperation. The longest follow-up was 40 months, and the total follow-up after the first year involved 94 patients, or 438 person-months (3632 person-years) of experience.
The step-wise regression analyses showed that preoperative variables can be of some use in selecting those patients who will derive benefit from surgery. The best preoperative variables for predicting overall outcome were congestive heart failure, degree of shock, degree of electrocardiographic changes, degree of mitral regurgitation, age, and NYHA preoperative class (table 11). Note that these six variables account for 30% of the variation in surgical outcome. When the surgical deaths are Xi = degree of congestive heart failure X2 = degree of electrocardiographic change X3 = degree of mitral regurgitation Considering a 0.7 probability of success as an adequate threshold for a predicted good result, figure 2 shows that good, although not absolute, predictability of outcome can be achieved if these Table 12   Table 11 Results of Step tThis is the sum of squared deviation of the actual values of the dependent variable from the predicted values based on the variables selected at the step and the preceding steps. At step zero the grand mean is used for prediction.
Circulation, Volume XLIX, January 1974 In terms of predicting overall outcome, the presence of clinical shock emerged as the second most important variable (table 11) . This is because 11 of the 25 patients dying at surgery were in some degree of preoperative clinical shock (5 in class III or IV-see Methods), which contributed to their mortality. Of the remaining 375 patients who survived the operation, only 12 were judged preoperatively to be clinically in shock; of these, only two were class III, with none in class IV. Thus, in describing variables which affect outcome for those surviving surgery (table 12) shock does not appear. Only congestive heart failure, degree of electrocardiographic changes, and mitral regurgitation had any significant impact on predicting overall outcome among those patients undergoing saphenous vein surgery without associated procedures (table 13) .
Other clinical features expected to affect outcome, such as age, number of grafts placed, or duration of pump time, had little further impact in reducing the sum of the squares. While each value may be important in an individual patient and should be considered clinically, these observations emphasize the importance of determining the patient's hemodynamic status preoperatively and suggests that the patient in congestive failure should receive critical clinical consideration preoperatively to determine whether the additional risks of surgery outweigh the potential benefits.
The attempt to quantitate the preoperative probability of successful surgical outcome using the Duncan-Walker method ( fig. 2) Although not absolute, our data suggest that in the properly selected patient, symptomatic improvement for angina pectoris can be expected in the majority of patients. While patient follow-up data to date do not permit any definite statement regarding patient survival and the reduction of myocardial infarction, our results suggest that patient survival may be enhanced. Careful and serial follow-up of these patients is planned during the ensuing five years.
